{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:51:22Z","timestamp":1790387482476,"version":"4.1.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Cancer cachexia is a frequent syndrome that affects patient quality of life, anticancer treatment effectiveness, and overall survival. The lack of anticancer cachexia therapies likely relies on the complexity of the syndrome that renders difficult to design appropriate clinical trials and, conversely, on the insufficient knowledge of the underlying pathogenetic mechanisms. The aim of this review is to collect the most relevant latest information regarding cancer cachexia with a special focus on the experimental systems adopted for modeling the disease in translational studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The scenario of preclinical models for the study of cancer cachexia is not static and is rapidly evolving in parallel with new prospective treatment options. The well established syngeneic models using rodent cancer cells injected ectopically are now used alongside new ones featuring orthotopic injection, human cancer cell or patient-derived xenograft, or spontaneous tumors in genetically engineered mice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The use of more complex animal models that better resemble cancer cachexia, ideally including also the administration of chemotherapy, will expand the understanding of the underlying mechanisms and will allow a more reliable evaluation of prospective drugs for translational purposes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/spc.0000000000000233","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T01:55:25Z","timestamp":1469238925000},"page":"281-287","source":"Crossref","is-referenced-by-count":62,"title":["Animal models for cancer cachexia"],"prefix":"10.1097","volume":"10","author":[{"given":"Riccardo","family":"Ballar\u00f2","sequence":"first","affiliation":[{"name":"Department of Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, University of Torino, Torino"},{"name":"Interuniversity Institute of Myology, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Costelli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, University of Torino, Torino"},{"name":"Interuniversity Institute of Myology, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Penna","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, University of Torino, Torino"},{"name":"Interuniversity Institute of Myology, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230926","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"R2-20230926","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13539-014-0149-7","article-title":"Are we closer to having drugs to treat muscle wasting disease?","volume":"5","author":"Morley","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R3-20230926","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.semcdb.2015.09.002","article-title":"Experimental cancer cachexia: evolving strategies for getting closer to the human scenario","volume":"54","author":"Penna","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"R4-20230926","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/ijc.29620","article-title":"Tumor inoculation site affects the development of cancer cachexia and muscle wasting","volume":"137","author":"Matsuyama","year":"2015","journal-title":"Int J Cancer"},{"key":"R5-20230926","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jcsm.12008","article-title":"Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signalling","volume":"6","author":"Dwarkasing","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R6-20230926","doi-asserted-by":"crossref","first-page":"43202","DOI":"10.18632\/oncotarget.6439","article-title":"Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations","volume":"6","author":"Pin","year":"2015","journal-title":"Oncotarget"},{"key":"R7-20230926","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jcsm.12023","article-title":"Ghrelin prevents tumour- and cisplatin-induced muscle wasting: Characterization of multiple mechanisms involved","volume":"6","author":"Chen","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R8-20230926","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/bjc.2014.379","article-title":"Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle","volume":"111","author":"Mirza","year":"2014","journal-title":"Br J Cancer"},{"key":"R9-20230926","doi-asserted-by":"crossref","first-page":"e113931","DOI":"10.1371\/journal.pone.0113931","article-title":"Distinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3","volume":"9","author":"Toledo","year":"2014","journal-title":"PLoS One"},{"key":"R10-20230926","doi-asserted-by":"crossref","first-page":"e0122660","DOI":"10.1371\/journal.pone.0122660","article-title":"Pioglitazone treatment increases survival and prevents body weight loss in tumor\u2013bearing animals: possible anti-cachectic effect","volume":"10","author":"Beluzi","year":"2015","journal-title":"PLoS One"},{"key":"R11-20230926","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/01635581.2015.1043021","article-title":"\u03b1-Linolenic fatty acid supplementation decreases tumor growth and cachexia parameters in Walker 256 tumor-bearing rats","volume":"67","author":"Schiessel","year":"2015","journal-title":"Nutr Cancer"},{"key":"R12-20230926","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/jcsm.12050","article-title":"Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting","volume":"7","author":"Penna","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R13-20230926","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jcsm.12035","article-title":"A multifactorial anticachectic approach for cancer cachexia in a rat model undergoing chemotherapy","volume":"7","author":"Toledo","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R14-20230926","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1517\/17460441.2015.1041914","article-title":"Developing models for cachexia and their implications in drug discovery","volume":"10","author":"Konishi","year":"2015","journal-title":"Expert Opin Drug Discov"},{"key":"R15-20230926","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mex.2015.02.001","article-title":"Storage conditions and passages alter IL-6 secretion in C26 adenocarcinoma cell lines","volume":"2","author":"Norden","year":"2015","journal-title":"MethodsX"},{"key":"R16-20230926","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s13539-014-0141-2","article-title":"Modeling human cancer cachexia in colon 26 tumor-bearing adult mice","volume":"5","author":"Talbert","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R17-20230926","doi-asserted-by":"crossref","first-page":"19976","DOI":"10.1074\/jbc.M115.638411","article-title":"A key role for leukemia inhibitory factor in C26 cancer cachexia","volume":"290","author":"Seto","year":"2015","journal-title":"J Biol Chem"},{"key":"R18-20230926","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.cell.2015.08.031","article-title":"Targeting of Fn14 prevents cancer-induced cachexia and prolongs survival","volume":"162","author":"Johnston","year":"2015","journal-title":"Cell"},{"key":"R19-20230926","doi-asserted-by":"crossref","first-page":"H685","DOI":"10.1152\/ajpheart.00106.2015","article-title":"Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia","volume":"309","author":"Devine","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R20-20230926","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.metabol.2016.01.014","article-title":"Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia","volume":"65","author":"Khamoui","year":"2016","journal-title":"Metabolism"},{"key":"R21-20230926","doi-asserted-by":"crossref","first-page":"6729268","DOI":"10.1155\/2016\/6729268","article-title":"Spontaneous physical activity downregulates pax7 in cancer cachexia","volume":"2016","author":"Coletti","year":"2016","journal-title":"Stem Cells Int"},{"key":"R22-20230926","doi-asserted-by":"crossref","first-page":"C101","DOI":"10.1152\/ajpcell.00344.2015","article-title":"Valproic acid attenuates skeletal muscle wasting by inhibiting C\/EBP\u03b2-regulated atrogin1 expression in cancer cachexia","volume":"311","author":"Sun","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"R23-20230926","doi-asserted-by":"crossref","first-page":"djv274","DOI":"10.1093\/jnci\/djv274","article-title":"Preclinical investigation of the novel histone deacetylase inhibitor AR-42 in the treatment of cancer-induced cachexia","volume":"107","author":"Tseng","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R24-20230926","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yjmcc.2015.05.007","article-title":"Losartan treatment attenuates tumor-induced myocardial dysfunction","volume":"85","author":"Stevens","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"R25-20230926","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2016.02.010","article-title":"Reactive oxygen species and calcium signals in skeletal muscle: a crosstalk involved in both normal signaling and disease","author":"Espinosa","year":"2016","journal-title":"Cell Calcium"},{"key":"R26-20230926","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2015.12.019","article-title":"Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice","volume":"91","author":"Assi","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"R27-20230926","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11010-014-2250-9","article-title":"Effects of celecoxib and ibuprofen on metabolic disorders induced by Walker-256 tumor in rats","volume":"399","author":"de Souza","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"R28-20230926","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1089\/jmf.2014.0129","article-title":"Oral administration of aloe vera (L.) Burm. f. (Xanthorrhoeaceae) and honey improves the host body composition and modulates proteolysis through reduction of tumor progression and oxidative stress in rats","volume":"18","author":"Tomasin","year":"2015","journal-title":"J Med Food"},{"key":"R29-20230926","doi-asserted-by":"crossref","DOI":"10.1007\/s00726-016-2172-9","article-title":"Creatine supplementation prevents hyperhomocysteinemia, oxidative stress and cancer-induced cachexia progression in Walker-256 tumor-bearing rats","author":"Deminice","year":"2016","journal-title":"Amino Acids"},{"key":"R30-20230926","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00520-010-0972-0","article-title":"Animal models of the cancer anorexia-cachexia syndrome","volume":"19","author":"Bennani-Baiti","year":"2011","journal-title":"Support Care Cancer"},{"key":"R31-20230926","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12116","article-title":"Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation","author":"Musolino","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R32-20230926","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201600250RR","article-title":"Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia","author":"Bohnert","year":"2016","journal-title":"FASEB J"},{"key":"R33-20230926","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/ijc.29930","article-title":"Complete reversal of muscle wasting in experimental cancer cachexia: additive effects of activin type II receptor inhibition and \u03b2-2 agonist","volume":"138","author":"Toledo","year":"2016","journal-title":"Int J Cancer"},{"key":"R34-20230926","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/ismej.2015.209","article-title":"Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia","volume":"10","author":"Bindels","year":"2016","journal-title":"ISME J"},{"key":"R35-20230926","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3324\/haematol.2015.138545","article-title":"Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2\u2212\/\u2212 c\u2212\/\u2212 mice","volume":"101","author":"Krombholz","year":"2016","journal-title":"Haematologica"},{"key":"R36-20230926","doi-asserted-by":"crossref","first-page":"e0143594","DOI":"10.1371\/journal.pone.0143594","article-title":"Supplementation of magnolol attenuates skeletal muscle atrophy in bladder cancer-bearing mice undergoing chemotherapy via suppression of FoxO3 activation and induction of IGF-1","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"R37-20230926","doi-asserted-by":"crossref","first-page":"41146","DOI":"10.18632\/oncotarget.5843","article-title":"Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth","volume":"6","author":"Shukla","year":"2015","journal-title":"Oncotarget"},{"key":"R38-20230926","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1158\/0008-5472.CAN-15-1740","article-title":"Detection of pancreatic cancer-induced cachexia using a fluorescent myoblast reporter system and analysis of metabolite abundance","volume":"76","author":"Winnard","year":"2016","journal-title":"Cancer Res"},{"key":"R39-20230926","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nm.4093","article-title":"Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia","volume":"22","author":"Fukawa","year":"2016","journal-title":"Nat Med"},{"key":"R40-20230926","doi-asserted-by":"crossref","first-page":"608","DOI":"10.15252\/emmm.201404430","article-title":"Comprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicine","volume":"7","author":"Castellsagu\u00e9","year":"2015","journal-title":"EMBO Mol Med"},{"key":"R41-20230926","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/164_2015_29","article-title":"Predictive in vivo models for oncology","volume":"232","author":"Behrens","year":"2016","journal-title":"Handb Exp Pharmacol"},{"key":"R42-20230926","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1152\/japplphysiol.00416.2015","article-title":"Eccentric contraction-induced myofiber growth in tumor-bearing mice","volume":"120","author":"Hardee","year":"2016","journal-title":"J Appl Physiol"},{"key":"R43-20230926","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/path.4142","article-title":"Activin-\u03b2c reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice","volume":"229","author":"Gold","year":"2013","journal-title":"J Pathol"},{"key":"R44-20230926","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jcsm.12031","article-title":"Activin-\u03b2C modulates cachexia by repressing the ubiquitin-proteasome and autophagic degradation pathways","volume":"6","author":"Marino","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R45-20230926","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jcp.24580","article-title":"Pancreatic cancer-induced cachexia is Jak2-dependent in mice","volume":"229","author":"Gilabert","year":"2014","journal-title":"J Cell Physiol"},{"key":"R46-20230926","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semcdb.2016.02.009","article-title":"STAT3 in the systemic inflammation of cancer cachexia","volume":"54","author":"Zimmers","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"R47-20230926","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1939-1676.2011.00838.x","article-title":"Cachexia and sarcopenia: emerging syndromes of importance in dogs and cats","volume":"26","author":"Freeman","year":"2012","journal-title":"J Vet Intern Med"},{"key":"R48-20230926","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jvc.2015.06.004","article-title":"Pilot study of a myostatin antagonist in dogs with cardiac cachexia","volume":"17","author":"Freeman","year":"2015","journal-title":"J Vet Cardiol"},{"key":"R49-20230926","article-title":"Differential effects of interleukin-6 and activin A in the development of cancer-associated cachexia","author":"Chen","year":"2016","journal-title":"Cancer Res"},{"key":"R50-20230926","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9779","article-title":"Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1\/2 and p38 MAPKs","author":"Barreto","year":"2016","journal-title":"Oncotarget"},{"key":"R51-20230926","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/jcsm.12083","article-title":"Request for regulatory guidance for cancer cachexia intervention trials","volume":"6","author":"Fearon","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201612000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T07:33:25Z","timestamp":1695713605000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201612000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000233","relation":{},"ISSN":["1751-4258","1751-4266"],"issn-type":[{"value":"1751-4258","type":"print"},{"value":"1751-4266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}